醒脑静注射液在心肺复苏中应用.docVIP

醒脑静注射液在心肺复苏中应用 　　摘要：目的 讨论研究醒脑静注射液在心肺复苏中的应用。方法 随机选取自2010年2月～2011年11月间通过心肺复苏救治成功的80例患者作为研究对象。并且根据患者实际情况记录其发生全身炎症反应的概率，并对结果进行统计分析。结果 AB两组患者的细胞因子含量水平均有所升高，在系统的治疗后，白细胞介素10的含量A组含量水平要比B组和治疗前的含量水平有明显下降，且P0.05，具有统计学意义。A组中患者的蛋白S100β的含量水平与B组中患者相比有明显的降低，P0.05，具有统计学意义。此外，在对患者进行心肺复苏后的72h后，A组患者发生全身炎症反应的几率要明显小于B组中的患者的发生率，差异明显具有统计学意义。结论 对于治疗通过心肺复苏抢救成功的患者，在其治疗早期对其采用醒脑静注射液滴注，可以有效地降低患者血清中的细胞因子的含量水平。并且能够有效地降低患者发生全身炎症反应综合症的几率。 　　关键词：醒脑静注射液；心肺复苏；临床应用 　　Awake Brain Injection in the Application of Cardiopulmonary Resuscitation （CPR） 　　WANG Gui-xian 　　（Dongli District Dongli Hospital，Tianjin 300300，China） 　　Abstract：Objective To discuss research XNJI applied cardiopulmonary resuscitation. Methods Randomly selected since February 2010 to November 2011 by the successful treatment of 80 patients with cardiopulmonary resuscitation as the research object. And the probability of occurrence of systemic inflammatory response of records based on the actual situation of the patient， and the results were analyzed statistically. Results The levels of cytokines AB were elevated in both groups of patients， after treatment system， interleukin-10 content of group A level content than the content of the previous group B and treatment have significantly decreased， and P 0.05， statistically significant. A group of patients in the levels of protein S100β compared with patients in group B had significantly lower， P 0.05， statistically significant. In addition， seventy-two hours after the patient after cardiopulmonary resuscitation， A group of patients with systemic inflammatory response was significantly less than the probability of the incidence of group B patients， the differences are significant statistically significant. Conclusion For patients rescued by cardiopulmonary resuscitation， early in their treatment of their adopted XNJI infusion， can effectively reduce the levels of serum cytokines. And can effectively reduce the occurrence of the patients chance of systemic inflammatory response syndrome.